small molecule program (ReveraGen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesmall molecule program (ReveraGen)
Drug Alias Namesmall molecule program (Validus Biopharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMuscular Atrophy, SpinalAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReveragen Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReveragen Biopharma Inc
Active IndicationsN/A
Inactive IndicationsMuscular Atrophy, SpinalAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A